Integrin α_IIbβ₃ exists in an activated state in subjects with elevated plasma homocysteine levels

References

• Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis RJ, Boers GH, Sheahan RG, Israelsson B, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997; 277: 1775–1781
   PubMed Web of Science ®Google Scholar
• Dawson PA, Cox AJ, Emmerson BT, Dudman NP, Kraus JP, Gordon RB. Characterisation of five missense mutations in the cystathionine beta-synthase gene from three patients with B6-nonresponsive homocystinuria. Eur J Hum Genet 1997; 5: 15–21
   PubMed Web of Science ®Google Scholar
• Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE. Molecular basis of cystathionine beta-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet 1993; 2: 1857–1860
   PubMed Web of Science ®Google Scholar
• McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969; 56: 111–128
   PubMed Web of Science ®Google Scholar
• Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149–1155
   PubMed Web of Science ®Google Scholar
• Wald DS, Wald NJ, Morris JK, Law M. Folic acid, homocysteine, and cardiovascular disease: Judging causality in the face of inconclusive trial evidence. BMJ 2006; 333: 1114–1117
   PubMed Web of Science ®Google Scholar
• Wilcken DE, Wilcken B. The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 1997; 20: 295–300
   PubMed Web of Science ®Google Scholar
• den Heijer M, Koster T, Blom HJ, Bos GM, Briet E, Reitsma PH, Vandenbroucke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 334: 759–62
   PubMed Web of Science ®Google Scholar
• Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: Current evidence and future prospects. Am J Med 2002; 112: 556–565
   PubMed Web of Science ®Google Scholar
• Jacobsen DW, Gatautis VJ, Green R, Robinson K, Savon SR, Secic M, Ji J, Otto JM, Taylor LM, Jr. Total plasma homocysteine: The mediator/marker controversy continues. Clin Chem 2009; 55: 1742–1743
   PubMed Web of Science ®Google Scholar
• Sass JO, Nakanishi T, Sato T, Sperl W, Shimizu A. S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia. Biochem Biophys Res Commun 2003; 310: 242–246
   PubMed Web of Science ®Google Scholar
• Majors AK, Sengupta S, Willard B, Kinter MT, Pyeritz RE, Jacobsen DW. Homocysteine binds to human plasma fibronectin and inhibits its interaction with fibrin. Arterioscler Thromb Vasc Biol 2002; 22: 1354–1359
   PubMed Web of Science ®Google Scholar
• Wagner CL, Mascelli MA, Neblock DS, Weisman HF, Coller BS, Jordan RE. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996; 88: 907–914
   PubMed Web of Science ®Google Scholar
• Kamata T, Ambo H, Puzon-McLaughlin W, Tieu KK, Handa M, Ikeda Y, Takada Y. Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit. Biochem J 2004; 378: 1079–1082
   PubMed Web of Science ®Google Scholar
• MacIntyre DE, Gordon JL. Evidence for two populations of disulphide bonds on blood platelets. Biochem Soc Trans. 1974; 2: 873
   Web of Science ®Google Scholar
• Peerschke EI. Regulation of platelet aggregation by post-fibrinogen binding events. Insights provided by dithiothreitol-treated platelets. Thromb Haemost 1995; 73: 862–867
   PubMed Web of Science ®Google Scholar
• Sun QH, Liu CY, Wang R, Paddock C, Newman PJ. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes. Blood 2002; 100: 2094–2101
   PubMed Web of Science ®Google Scholar
• Yan B, Smith JW. A redox site involved in integrin activation. J Biol Chem 2000; 275: 39964–39972
   PubMed Web of Science ®Google Scholar
• Zucker MB, Masiello NC. Platelet aggregation caused by dithiothreitol. Thromb Haemost 1984; 51: 119–124
   PubMed Web of Science ®Google Scholar
• Lahav J, Jurk K, Hess O, Barnes MJ, Farndale RW, Luboshitz J, Kehrel BE. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002; 100: 2472–2478
   PubMed Web of Science ®Google Scholar
• O'Neill S, Robinson A, Deering A, Ryan M, Fitzgerald DJ, Moran N. The platelet integrin alphaIIb beta3 has an endogenous thiol isomerase activity. J Biol Chem 2000; 275: 36984–36990
   PubMed Web of Science ®Google Scholar
• Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995; 41: 991–994
   PubMed Web of Science ®Google Scholar
• Lauricella AM, Quintana I, Castanon M, Sassetti B, Kordich L. Influence of homocysteine on fibrin network lysis. Blood Coagul Fibrinolysis 2006; 17: 181–186
   PubMed Web of Science ®Google Scholar
• Sauls DL, Wolberg AS, Hoffman M. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: Implications for the mechanism of thrombosis in hyperhomocysteinemia. J Thromb Haemost 2003; 1: 300–306
   PubMed Web of Science ®Google Scholar
• Skurk C, Walsh K. Death receptor induced apoptosis: A new mechanism of homocysteine-mediated endothelial cell cytotoxicity. Hypertension 2004; 43: 1168–1170
   PubMed Web of Science ®Google Scholar
• Zhang C, Kawauchi J, Adachi MT, Hashimoto Y, Oshiro S, Aso T, Kitajima S. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine. Biochem Biophys Res Commun 2001; 289: 718–724
   PubMed Web of Science ®Google Scholar
• Leoncini G, Pascale R, Signorello MG. Effects of homocysteine on l-arginine transport and nitric oxide formation in human platelets. Eur J Clin Invest 2003; 33: 713–719
   PubMed Web of Science ®Google Scholar
• Mutus B, Rabini RA, Staffolani R, Ricciotti R, Fumelli P, Moretti N, Martarelli D, Mazzanti L. Homocysteine-induced inhibition of nitric oxide production in platelets: A study on healthy and diabetic subjects. Diabetologia 2001; 44: 979–982
   PubMed Web of Science ®Google Scholar
• Riba R, Nicolaou A, Troxler M, Homer-Vaniasinkam S, Naseem KM. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis 2004; 175: 69–75
   PubMed Web of Science ®Google Scholar
• Spencer CG, Martin SC, Felmeden DC, Blann AD, Beevers GD, Lip GY. Relationship of homocysteine to markers of platelet and endothelial activation in “high risk” hypertensives: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Int J Cardiol 2004; 94: 293–300
   PubMed Web of Science ®Google Scholar
• Graeber JE, Slott JH, Ulane RE, Schulman JD, Stuart MJ. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism. Pediatr Res 1982; 16: 490–493
   PubMed Web of Science ®Google Scholar
• Signorello MG, Pascale R, Leoncini G. Effect of homocysteine on arachidonic acid release in human platelets. Eur J Clin Invest 2002; 32: 279–284
   PubMed Web of Science ®Google Scholar
• Olas B, Kedzierska M, Wachowicz B. Comparative studies on homocysteine and its metabolite-homocysteine thiolactone action in blood platelets in vitro. Platelets 2008; 19: 520–527
   PubMed Web of Science ®Google Scholar
• Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997; 11: 1157–1168
   PubMed Web of Science ®Google Scholar
• Fuglsang J, Stender M, Zhou J, Moller J, Falk E, Ravn HB. Platelet activity and in vivo arterial thrombus formation in rats with mild hyperhomocysteinaemia. Blood Coagul Fibrinolysis 2002; 13: 683–689
   PubMed Web of Science ®Google Scholar
• Mohan IV, Jagroop IA, Mikhailidis DP, Stansby GP. Homocysteine activates platelets in vitro. Clin Appl Thromb Hemost 2008; 14: 8–18
   PubMed Web of Science ®Google Scholar
• Sundaramoorthy E, Maiti S, Brahmachari SK, Sengupta S. Predicting protein homocysteinylation targets based on dihedral strain energy and pKa of cysteines. Proteins 2008; 71: 1475–1483
   PubMed Web of Science ®Google Scholar
• Walsh GM, Sheehan D, Kinsella A, Moran N, O'Neill S. Redox modulation of integrin [correction of integin] alpha IIb beta 3 involves a novel allosteric regulation of its thiol isomerase activity. Biochemistry 2004; 43: 473–480
   PubMed Web of Science ®Google Scholar